Global Transcriptomics Market Outlook, 2029

The Global Transcriptomics Market is estimated at USD 5.8 billion in 2020 , driven by Rising demand for personalized medicine.

According to publisher, Here is the Global Transcriptomics Market Report. Market Insights The global transcriptomics market is experiencing steady growth, driven by advancements in technology and increasing applications across various fields. Here are some key insights:

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market size: Estimates vary, but the market was valued around $5.8 billion in 2020 and is projected to reach $11-28 billion by 2030, indicating a Compound Annual Growth Rate (CAGR) of 6.5-20%. Rising demand for personalized medicine: Tailoring treatments to individual patients' genetic makeup is a major driver. Transcriptomics helps identify gene expression variations linked to specific diseases. Market Dynamics Several factors influence the market's growth: Technological advancements: Next-generation sequencing (NGS) is revolutionizing transcriptomics. Companies like Illumina offer advanced NGS platforms enabling comprehensive analysis of gene expression [Example: Illumina NovaSeq 6000 sequencing system]. Growing R&D expenditure: Pharmaceutical and biotechnology companies are investing heavily in R&D, fueling the demand for transcriptomics tools for drug discovery and development. Market Segments

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

The transcriptomics market can be segmented based on: Technology: Microarray, Real-time quantitative PCR (qPCR), and Sequencing Technologies (dominant segment) Product: Consumables (enzymes, reagents), Instruments (sequencers, PCR machines), and Other Products (software) Application: Diagnostics & Disease Profiling (largest segment), Drug Discovery, and Other Applications (functional genomics) Regional Analysis North America currently dominates the market due to the presence of established pharmaceutical and biotechnology companies, along with high government funding for research. However, Asia-Pacific is expected to witness the fastest growth due to rising investments in life sciences and growing disease burdens.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Key Developments Launch of new products: Companies are continuously developing novel tools and technologies. For instance, Thermo Fisher introduced the Ion Torrent Genexus System, a benchtop NGS platform for targeted transcriptome analysis. Increasing collaborations: Strategic partnerships between research institutions and life science companies are accelerating advancements in the field. Competitive Landscape The market is moderately competitive with a mix of major players and emerging companies. Some key players include: Illumina Thermo Fisher Scientific F. Hoffmann-La Roche Ltd. Agilent Technologies QIAGEN These companies are focusing on product innovation, strategic acquisitions, and expanding their geographical reach to maintain a competitive edge. In Conclusion The global transcriptomics market offers significant growth potential due to its expanding applications in healthcare, research, and personalized medicine. Technological advancements, rising R&D investments, and growing awareness are expected to propel the market forward in the coming years.

Table of Contents

  • Table Of Contents
  • Figures And Tables
  • Part 1. Introduction
  • 1.1 Description
  • 1.2 Objectives Of The Study
  • 1.3 Market Segment
  • 1.4 Years Considered For The Report
  • 1.5 Currency
  • 1.6 Key Target Audience
  • Part 2. Research Methodology
  • 2.1 Primary Research
  • 2.2 Secondary Research
  • Part 3. Executive Summary
  • Part 4. Market Overview
  • 4.1 Introduction
  • 4.2 Drivers
  • 4.3 Restraints
  • Part 5. Global Transcriptomics Market By Component
  • 5.1 Consumables
  • 5.2 Instruments
  • 5.3 Software
  • Part 6. Global Transcriptomics Market By Technology
  • 6.1 Next-Generation Sequencing
  • 6.2 Polymerase Chain Reaction
  • 6.3 Microarray
  • 6.4 Mass Cytometry
  • 6.5 Others
  • Part 7. Global Transcriptomics Market By Application
  • 7.1 Drug Discovery And Development
  • 7.2 Diagnostics
  • 7.3 Cell Biology
  • 7.4 Single Cell Analysis
  • 7.5 Gene Expression
  • 7.6 Others
  • Part 8. Global Transcriptomics Market By End User
  • 8.1 Academic
  • 8.2 Pharmaceutical Companies
  • 8.3 Others
  • Part 9. Global Transcriptomics Market By Region
  • 9.1 North America
  • 9.2 Europe
  • 9.3 Asia-Pacific
  • 9.4 Mea (Middle East And Africa)
  • 9.5 Latin America
  • Part 10. Company Profiles
  • 10.1 Pacific Biosciences Of California, Inc.
  • 10.2 Thermo Fisher Scientific, Inc.
  • 10.3 Agilent Technologies, Inc.
  • 10.4 Illumina, Inc.
  • 10.5 Qiagen, N.V.
  • 10.6 Bio-Rad Laboratories, Inc.
  • 10.7 Takara Bio Inc.
  • 10.8 Perkinelmer Inc.
  • 10.9 Standard Biotools Inc.
  • 10.10 10X Genomics, Inc.
  • 10.11 Nanostring Technologies, Inc.
  • 10.12 Becton, Dickinson And Company (Bd)
  • 10.13 Bio-Techne Corporation
  • 10.14 Pall Corporation
  • 10.15 Biospyder Technologies Inc.
  • 10.16 Angle Plc
  • 10.17 Menarini Silicon Biosystems S.P.A.
  • Disclaimer


Global Transcriptomics Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.